An Outcomes Assessment of the Utility of Belladerm Acellular Dermal Allograft in Ocular Lower Lid Retraction Repair

Completed · Not applicable

Conditions studied: Lower Eyelid Retraction

In brief

The purpose of this study is to Evaluate the efficacy and longevity of a Human-derived, non-cadaveric, acellular dermal implant (BellaDerm) as a posterior spacer graft in the correction of lower eyelid retraction, taking into consideration issues associated with the use of acelular dermis such as contraction and potential regression of repairs.

Key facts

Study ID

NCT02133495

Run by

SGM Physician Research Consortium

People needed

12

Starts

2011-01-01

Expected to finish

2014-01-01

Last updated by the study team

2014-05-08

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Lower eyelid retraction, defined as inferior displacement of the lower eyelid margin with inferior scleral show, may be asymptomatic
• May have ocular irritation including foreign body sensation, burning, photophobia and tearing.
• May have aesthetically unsatisfactory eyelid appearance.

You may not qualify if…

• Have a condition that would be contraindicated to surgery

Where it is running

• Morgenstern Center for Orbital and Facial Plastic Surgery — Wayne, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.